Accession Number:

ADA512546

Title:

Generation and Evaluation of PEGylated Recombinant Human Acetylcholinesterase as an Optimal OP-Bioscavenger

Descriptive Note:

Final rept. 5 Jul 2006-31 Dec 2008

Corporate Author:

ISRAEL INST FOR BIOLOGICAL RESEARCH NESS ZIONA

Report Date:

2009-04-27

Pagination or Media Count:

26.0

Abstract:

We have shown in the past that recombinant human AChE rHuAChE can be converted into circulatory long-lived molecular forms by conjugation of polyethylene glycol PEG chains to lysine residues. In the present study, we determined the factors that govern circulatory residence of PEGylated AChE, and established the lysine mutant configurations that allow maximal circulatory longevity. We further demonstrated that PEGylated rHuAChEs are less immunogenic than non-modified enzyme. In addition, we incorporated favorable kinetic characteristics for OP-scavenging into the rHuAChE enzyme, utilizing genetic engineering methods. Thus, incorporation of the F338A mutation into circulatory long-lived PEG-hypolysine AChE resulted in an enzyme displaying reduced aging rates that could protect mice against repeated OP-compound exposures. Finally, we established a method for production of enzymatically active rHAChE at appreciable amounts and relatively low cost utilizing the Pichia pastoris yeast cell system. Taken together, these different lines of study pave the way for large-scale production of PEGylated recombinant human AChE derivatives displaying catalytic and pharmacokinetic properties optimized for effective in-vivo bioscavenging of OP-compounds.

Subject Categories:

  • Biochemistry
  • Pharmacology
  • Chemical, Biological and Radiological Warfare

Distribution Statement:

APPROVED FOR PUBLIC RELEASE